Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $42.9600 (2.07%) ($42.9600 - $42.9600) on Fri. Apr. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.85% (three month average) | RSI | 41 | Latest Price | $42.9600(2.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(47%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.425% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) IGOV(-3%) GLD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.425% (StdDev 2.85%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $42.55(0.96%) | 10 Day Moving Average | $42.02(2.24%) | 20 Day Moving Average | $42.64(0.75%) | To recent high | -17.3% | To recent low | 8.5% | Market Cap | $5.871b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |